And yes, it does include provisions for a notification-based supplements system.
China has given us the first official glimpse of how the country may rewrite its regulations for dietary supplements. The U.S.-China Health Products Association announced that, on November 5, China’s FDA released two draft documents, “Administrative Regulations for Nutritional Supplements” and “Information Requirement for Nutritional Supplements.”
The drafts confirm that China’s FDA will create a notification-based system for nutritional supplements, instead of the country’s current, problematic “blue hat” product-registration system, as previously reported by Nutritional Outlook, thanks to insights from the USCHPA. This complicated and costly “blue hat” system has stalled the supplements business in China and dampened outside investment in the China health products market.
The new draft documents confirm that the easier-to-navigate notification system would cover only vitamin and mineral supplements, a category whose safety and effectiveness China considers well established.
USCHPA, which has been highly involved in talks with China’s FDA about changing the regulatory framework, says it is in the process of translating the new draft documents and plans to issue comments to China’s FDA by the end of the November. The new regulations could be effective as early as next year, USHCPA says.
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine jennifer.grebow@ubm.com
Photo © iStockphoto.com/jpa1999
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.